These included age at diagnosis, disease stage, tumor size, tumor grade, steroid receptor status (estrogen and progesterone receptors), lymph node status, adjuvant treatment (chemotherapy, hormone therapy) and clinical outcomes such as recurrence and survival information. The gene discussed is PGR; the disease is neoplasm.